Fed Circuit orders new trial in Abbott drug test patent case [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Fed Circuit orders new trial in Abbott drug test patent case A U.S. appeals court on Friday granted patent monetization company Rembrandt IP Management a new trial in an infringement case it brought against an Abbott Laboratories diagnostic testing subsidiary. The U.S. Court of Appeals for the Federal Circuit said a retrial was warranted because a California judge had misinterpreted key terms in a Rembrandt patent on drug testing technology. To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2y84srp
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- $613+ Billion Global Generic Drugs Market is Expected to Grow at a CAGR of over 5.10% During 2023-2030 | Vantage Market Research [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- Stroke Management Market to reach $74 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- Digital Diabetes Management Market to Hit USD 22.47 Billion by 2030 Driven by Rising Diabetes Prevalence Globally and Supportive Regulatory Environment | Research by SNS Insider [Yahoo! Finance]Yahoo! Finance
- Cough Suppressant Market is expected to US$ 50,948.51 Million by 2034: Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/18/23 - Beat
ABT
Sec Filings
- 11/1/23 - Form 10-Q
- 10/30/23 - Form 4
- 10/26/23 - Form 144
- ABT's page on the SEC website